S. Markabi

The effects of a flexible visual acuity-driven ranibizumab treatment regimen in age-related macular degeneration: outcomes of a drug and disease model.

P. Mitchell, U. Schmidt-Erfurth, J. Korobelnik, 2010, Investigative ophthalmology & visual science.

Improving efficiency of ALS clinical trials: a sponsor's perspective

S. Markabi, J. Schadrack, 2002, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

Carbamazepine in agitation and aggressive behaviour following severe closed-head injury: results of an open trial.

B. Bussel, P. Azouvi, N. Attal, 1999, Brain injury.

Oxcarbazepine Pharmacokinetics and Tolerability in Children With Inadequately Controlled Epilepsy

O. Dulac, C. Bulteau, J. Motte, 2004, Journal of clinical pharmacology.

Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson’s Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multicentre open-label study

M. Onofrj, A. Thomas, F. Vingerhoets, 2004, Journal of Neural Transmission.

Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist.

H. Diener, G. Albers, S. Davis, 2000, Stroke.

Efficacy and Safety of Ritalin® LA™, a New, Once Daily, Extended-Release Dosage Form of Methylphenidate, in Children with Attention Deficit Hyperactivity Disorder

J. Biederman, S. Wigal, M. Weiss, 2003, Paediatric drugs.

Comparative effects of low and high doses of clomipramine and placebo in panic disorder: a double‐blind controlled study

F. Rouillon, V. Caillard, S. Markabi, 1999, Acta psychiatrica Scandinavica.

1 – Selfotel (CGS19755)

M. Schmutz, D. Murphy, D. Sauer, 1997 .